Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests

Tapping GSK tech, Medicago kickstarts later-stage COVID vax tests

Source: 
Fierce Biotech
snippet: 

After signing up to use GlaxoSmithKline’s adjuvant vaccine technology back in the summer, Canadian biotech Medicago has already finished off a phase1, and is now kicking on with several phase 2/3 trials.